STRATEGY FOR IMPROVING PRIMARY SEPSIS
OUTCOMES USING LACTATE TESTING
|
|
||||
|
STRATEGY FOR IMPROVING
PRIMARY SEPSIS OUTCOMES USING LACTATE TESTING PRESENTERS Teresa Arrington, MBA, PMP, LSSMBB System Quality & Patient Safety Director, Ochsner Health New Orleans, LA Lisa Birdsall Fort, MD, MPH Emergency Medicine Ochsner Health New Orleans, LA SUMMARY There is a need for expanded POC lactate testing across EDs for improved sepsis care. Using POCT allows for rapid results from important labs like lactates, which are a critical part of clinical decision-making in the context of sepsis. This webinar covers one hospital system’s journey to incorporate lactate testing into the standard of care for patients who present to the ED with symptoms of sepsis, and their successful ‘sepsis drive-team’ structure, with the goal of reducing: • Delays in patient care • Testing burden on lab staff • Morbidity and Mortality |
Learning objectives
Continuing Education: - This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563 Click on 'Recording' to open a recording request form in your browser. After submitting the form, you will be redirected automatically to the recording. You will also be sent an email with the link to the PACE evaluation. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation. |
||||
|
|
||||
|
EVOLUTION OF SEPSIS GUIDELINES PRESENTER Lori Muhr DNP, MHSM/MHA, APRN-Rx, ACNS-BC, CCRN, CEN, LSS-BBC SUMMARY The Society of Critical Care Medicine reports that sepsis affects approximately 1.7 million patients each year, resulting in over 270,000 deaths1. Sepsis carries a greater mortality than Breast Cancer and AIDS combined2, costing over $24 billion dollars annually3. Early identification and treatment has been shown to reduce mortality by nearly 50% with the completion of the Sepsis Care bundles4. Over 85% of sepsis patients arrive to the hospital with Sepsis5, so an evidence-based process for early detection and treatment is key to reducing complications and mortality. The Surviving Sepsis Guidelines are a systematic, standardized evidence-based approach to the early recognition and treatment of the sepsis patient. Average length of stay (LOS) for the septic shock patient is 16.5 days with a cost of approximately $19,000 per case6. Sepsis accounts for 13% of total U.S. hospital costs7, with early recognition in both the ED and ICU the average LOS can be reduced8. The use of the Sepsis Care bundles results in better patient outcomes, shorter length of stay, and an overall reduction in sepsis mortality9. Understanding the evolution of the Sepsis Care bundles and how each member of the healthcare team can contribute to the recognition and treatment of sepsis is vital to the patient care process. A key component of treatment is utilizing the SIRS (Systemic Inflammatory Response Syndrome) criteria early in the ED and using the qSOFA (Quick Sequential Organ Failure Assessment) after admission to help facilitate early sepsis recognition. |
Learning objectives
Continuing Education: - This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563 - This program has been approved by the American Association of Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 24306. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned. After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation. |
||||
|
1Centers
for Disease Control and Prevention. 2021. Sepsis Clinical
Information. [online] Available at: [Accessed 1 June 2021]. 2UCLA Health. 2021. The World Sepsis Day Fact Sheet. [online] Available at: [Accessed 1 June 2021]. 3Paoli, C., 2021. Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level. [online] NCBI. Available at: [Accessed 1 June 2021]. 4Vincent, J., 2021. Reducing mortality in sepsis: new directions. [online] NCBI. Available at: [Accessed 1 June 2021]. 52021. Sepsis Fact Sheet. [ebook] Available at: [Accessed 1 June 2021]. 6Paoli, C., 2021. Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level. [online] NCBI. Available at: [Accessed 1 June 2021]. 7Padkin, A., 2021. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. [online] Society of Critical Care Medicine. Available at: [Accessed 1 June 2021]. 8Hackethal, V., 2018. Fewer Deaths After Sepsis Protocol Mandate. [online] Medscape. Available at: [Accessed 1 June 2021]. 9Hackethal, V., 2018. Fewer Deaths After Sepsis Protocol Mandate. [online] Medscape. Available at: <https://www.medscape.com/viewarticle/901712> [Accessed 1 June 2021]. |
|||||
COVID-19 LESSONS LEARNED SERIES: RESPIRATORY THERAPY BEST PRACTICES FOR TREATMENT AND PATIENT CARE STRATEGIES
|
|
||||
| COVID-19
LESSONS LEARNED SERIES: RESPIRATORY THERAPY BEST PRACTICES FOR TREATMENT AND PATIENT CARE STRATEGIES PRESENTER Vickie Carver-Parker, MBA, RRT, RPFT University of Tennessee Medical Center Knoxville, TN SUMMARY As healthcare systems continue struggle to deal with the impact of the COVID-19 pandemic and plan for an uncertain future, sweeping changes have occurred across the healthcare continuum. From ethical staffing considerations to specific patient care protocols, hospitals have adjusted multiple processes to deal with the immediate challenges posed by an influx of patients, while preparing for the “new normal” that lies ahead. This webinar will focus on the experiences and lessons learned from the perspective of an academic medical respiratory therapy manager. At the conclusion of the presentation, participants will gain a better understanding of respiratory therapy patient care strategies, ventilator and treatment protocols, staff and patient safety recommendations, blood gas testing processes, and what key steps facilities should take to prepare for a potential second-wave of increased patient volume as we head into a respiratory season of unknown severity. |
Learning objectives
Continuing Education: - This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563 - This program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC). - This program has been approved by the American Association of Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 23275. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned. After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation. |
||||
LESSONS LEARNED FROM THE EPICENTER
SERIES:
COVID-19 EMERGENCY MEDICINE BEST PRACTICES FROM THE FRONT
LINES OF A HOUSTON, TEXAS MEDICAL CENTER
|
|
||||
| LESSONS
LEARNED FROM THE EPICENTER SERIES: COVID-19 EMERGENCY MEDICINE
BEST PRACTICES FROM THE FRONT LINES OF A HOUSTON, TEXAS MEDICAL
CENTER PRESENTER W. Frank Peacock, MD, FACEP, FACC, FESC Professor, Vice Chair for Research Henry JN Taub Department of Emergency Medicine Baylor College of Medicine Houston, Texas SUMMARY As healthcare systems continue to struggle to deal with the impact of the COVID-19 pandemic and plan for an uncertain future, sweeping changes have occurred across the healthcare continuum. From triage strategies to specific patient care protocols, hospitals have adjusted multiple processes to deal with the immediate challenges posed by an influx of patients, while preparing for the “new normal” that lies ahead. This second installment of our COVID-19 webinar series will focus on the experiences and lessons learned from the perspective of a Houston, Texas emergency department physician. At the conclusion of the presentation, participants will gain a better understanding of emergency department triage strategies, treatment protocols, staff and patient safety recommendations, lab testing processes, and key steps facilities should take to prepare for a potential second-wave of increased patient volume as we head into a flu season of unknown severity. |
Learning objectives
Continuing Education: After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation. |
||||
LESSONS LEARNED FROM THE EPICENTER
SERIES:
COVID 19 BEST PRACTICES FROM A NEW YORK CITY HOSPITAL
|
|
||||
| LESSONS
LEARNED FROM THE EPICENTER: COVID 19 BEST PRACTICES FROM A NEW
YORK CITY HOSPITAL PRESENTER Wren Lester, PhD, CPHQ, CPXP, LSSBB Chief Experience Officer SUMMARY As healthcare systems struggle to deal with the immediate impact of the COVID-19 pandemic and plan for an uncertain future, sweeping changes have occurred across the healthcare continuum. Hospitals have adjusted multiple processes and staffing strategies to deal with the immediate challenges posed by an influx of patients, while preparing for the “new normal” that lies ahead. This webinar will be held in a discussion/interview format and will focus on the experiences and lessons learned from a hospital administrator at the center of the initial outbreak in New York City. At the conclusion of the presentation, participants will gain a better understanding of work force and patient safety recommendations, how hospitals must change patient-care processes, and key steps facilities should take to prepare for a potential second-wave of increased patient volume. |
Learning objectives
Continuing Education: After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation. |
||||
TROPONIN ESSENTIAL GUIDELINES: A PRACTICAL IMPLEMENTATION GUIDE
|
|
||||
|
TROPONIN ESSENTIAL
GUIDELINES: A PRACTICAL IMPLEMENTATION GUIDE PRESENTER Ruth Cantu, BSN, RN, AACC Accreditation Product Development ACC Accreditation Services SUMMARY This presentation will address the updates for Myocardial Infarction Guidelines which are important for clinicians and laboratorians as they provide valuable information on the new recommendations for serial Troponins as well as assay specifications. Information regarding Acute Coronary Syndromes (ACS) will provide a summary of statistics along with definitions of indicators under ACS. The methods for treating Myocardial Infarction (MI), also known as Acute MI or heart attack, including the acute phase in the ED as well as the diagnostic expectations for patients in observation status requiring accelerated serial marker protocols will also be discussed. The presentation will include a brief over-view of the high-sensitive Troponin and discussion on Troponin Turn-Around-Time (TAT), testing methodologies and a review of quality practices to optimize patient care. |
Learning objectives
Continuing Education: After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation. |
||||
PROCESS REDESIGN IN AMBULATORY EMERGENCY
CARE
UTILISING POINT OF CARE TESTING
|
|
|||
|
PROCESS REDESIGN IN AMBULATORY
EMERGENCY CARE UTILISING POINT OF CARE TESTING PRESENTER Phil Weihser BSc. PGCert. MSc. James Paget University Hospital NHS Trust, UK SUMMARY Emergency departments in many countries are suffering from overcrowding and increased admission rates. This is due to numerous factors such as a rise in chronic disease, an ageing population and access to care. Many healthcare systems are looking at models of care to help reduce the burden on acute services by decreasing the length of stay in hospital, and by reducing the number of unnecessary admissions. This webinar highlights how a university hospital in the UK has tackled the problem, by implementing a 7-day Ambulatory Emergency Care service (AEC). The speaker will highlight the clinical, financial and operational benefits achieved through the novel use of point of care testing, evidence-based service redesign, condition specific pathways, and access to senior clinical decision makers. |
Learning objectives
This event is produced by Whitehat Communications and sponsored by Abbott Point of Care. |
|||
ACT TESTING
|
|
||||
|
ACT
TESTING: WHEN THERE'S NO ROOM FOR DOUBT PRESENTER Dr. Florian Falter, MD Royal Papworth Hospital, UK SUMMARY ACT tests with some traditional analysers can lead to highly variable results, raising doubt about the accuracy of critical results1. Additionally, some second generation systems have diverged from using the traditional standard Celite and Kaolin activator biochemistry. In this educational webinar, Dr.Falter will introduce different ACT technologies and discuss best use of modern ACT testing technology. He will also discuss the clinical impact that different ACT analysis methods can have, along with key laboratory aspects of coagulation testing during cardiac surgery. 1 Reference: Ojito JW et al. J Extra Corpor Technol 2012;44:15-20 |
Learning objectives
Continuing Education: One P.A.C.E.® contact hour will be provided for this basic level session until December 4, 2018. Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563 This event is produced by Whitehat Communications and sponsored by Abbott Point of Care. |
||||
TROPONIN ESSENTIALS
|
|
||||
|
TROPONIN ESSENTIALS: IMPLEMENTING THE GUIDELINES PRESENTER Ruth Cantu, BSN, RN, AACC Program Manager, ACC Accreditation Services Summary The detection of a rise and/or fall of cardiac troponin plays a key role in identification of patients suspected of having an Acute Coronary Syndrome (ACS) and earlier diagnosis of myocardial infarction. However, individuals with non-ACS conditions can also have elevated cardiac troponin and many symptoms associated with non-ACS conditions may overlap with symptoms of ACS1. This presents a diagnostic challenge to the clinician and often requires an extended evaluation before the clinician can make an accurate diagnosis, which can impact efficiency and quality of care. This webinar will share an evidence-based approach to diagnosis and treatment of the ACS patient, with a focus on the current guidelines for troponin testing. |
Learning objectives
|
||||
| Reference: 1. Third
Universal Definition of Myocardial Infarction (MI), Kristian
Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons,
Bernard R. Chaitman and Harvey D. White, Circulation
2012;126:2020-2035 www.scpc.org/resources/PDFs/ThirdUniversalDefinitionofMyocardialInfarction_CIRC2012.pdf |
|||||
 |
|||||